Literature DB >> 24049428

Drug shortages pose problems for p&t committees in accountable care organizations.

James T O'Donnell, F Randy Vogenberg.   

Abstract

Drugs in short supply, especially those needed in oncology, can create legal and patient-safety problems for risk-bearing providers.

Entities:  

Keywords:  Medicare; P&T committee; accountable care organizations; drug shortages; health care reform; medication errors

Year:  2013        PMID： 24049428      PMCID： PMC3776493     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  9 in total

1.  Computerized reminders reduce the use of medications during shortages.

Authors:  Benjamin Bogucki; Brian R Jacobs; John Hingle
Journal:  J Am Med Inform Assoc       Date:  2004-04-02       Impact factor: 4.497

2.  Chemotherapy drug shortages in the United States: genesis and potential solutions.

Authors:  Michael P Link; Karen Hagerty; Hagop M Kantarjian
Journal:  J Clin Oncol       Date:  2012-01-30       Impact factor: 44.544

3.  The drug shortage crisis in the United States: causes, impact, and management strategies.

Authors:  C Lee Ventola
Journal:  P T       Date:  2011-11

4.  Impact of drug shortages on U.S. health systems.

Authors:  Rola Kaakeh; Burgunda V Sweet; Cynthia Reilly; Colleen Bush; Sherry DeLoach; Barb Higgins; Angela M Clark; James Stevenson
Journal:  Am J Health Syst Pharm       Date:  2011-10-01       Impact factor: 2.637

5.  Accountable care organizations, the patient-centered medical home, and health care reform: what does it all mean?

Authors:  David L Longworth
Journal:  Cleve Clin J Med       Date:  2011-09       Impact factor: 2.321

Review 6.  Shortage of perioperative drugs: implications for anesthesia practice and patient safety.

Authors:  Gildasio S De Oliveira; Luke S Theilken; Robert J McCarthy
Journal:  Anesth Analg       Date:  2011-05-19       Impact factor: 5.108

7.  Medicine. Shortages of cancer drugs put patients, trials at risk.

Authors:  Jocelyn Kaiser
Journal:  Science       Date:  2011-04-29       Impact factor: 47.728

8.  Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer.

Authors:  Laura J Havrilesky; Craig F Garfield; Jason C Barnett; David E Cohn
Journal:  Gynecol Oncol       Date:  2012-03-23       Impact factor: 5.482

9.  The impact of drug shortages on children with cancer--the example of mechlorethamine.

Authors:  Monika L Metzger; Amy Billett; Michael P Link
Journal:  N Engl J Med       Date:  2012-12-27       Impact factor: 91.245
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.